- Home
- OABI vs EHI Comparison
OABI vs EHI Comparison
Compare OABI & EHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- EHI
- Stock Information
- Founded
- OABI 2012
- EHI 2003
- Country
- OABI United States
- EHI United States
- Employees
- OABI N/A
- EHI N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- EHI Investment Managers
- Sector
- OABI Health Care
- EHI Finance
- Exchange
- OABI Nasdaq
- EHI Nasdaq
- Market Cap
- OABI 227.4M
- EHI 194.8M
- IPO Year
- OABI N/A
- EHI N/A
- Fundamental
- Price
- OABI $1.66
- EHI $6.54
- Analyst Decision
- OABI Strong Buy
- EHI
- Analyst Count
- OABI 3
- EHI 0
- Target Price
- OABI $6.67
- EHI N/A
- AVG Volume (30 Days)
- OABI 595.9K
- EHI 44.5K
- Earning Date
- OABI 11-11-2025
- EHI 01-01-0001
- Dividend Yield
- OABI N/A
- EHI 11.54%
- EPS Growth
- OABI N/A
- EHI N/A
- EPS
- OABI N/A
- EHI N/A
- Revenue
- OABI $23,027,000.00
- EHI N/A
- Revenue This Year
- OABI N/A
- EHI N/A
- Revenue Next Year
- OABI $48.74
- EHI N/A
- P/E Ratio
- OABI N/A
- EHI N/A
- Revenue Growth
- OABI 6.05
- EHI N/A
- 52 Week Low
- OABI $1.22
- EHI $6.00
- 52 Week High
- OABI $4.87
- EHI $7.75
- Technical
- Relative Strength Index (RSI)
- OABI 49.38
- EHI 43.33
- Support Level
- OABI $1.58
- EHI $6.49
- Resistance Level
- OABI $1.72
- EHI $6.60
- Average True Range (ATR)
- OABI 0.08
- EHI 0.06
- MACD
- OABI 0.02
- EHI -0.01
- Stochastic Oscillator
- OABI 65.15
- EHI 22.14
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About EHI Western Asset Global High Income Fund Inc
Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income and total return by investing in a world-wide portfolio of securities. The fund invests in various sectors such as Consumer Discretionary, Energy, Healthcare, Industrials, materials, and others.